Iriban may be available in the countries listed below.
Mebeverine hydrochloride (a derivative of Mebeverine) is reported as an ingredient of Iriban in the following countries:
International Drug Name Search
Amprace may be available in the countries listed below.
Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Amprace in the following countries:
International Drug Name Search
Dolophine Solution may cause severe and sometimes fatal heart and breathing problems. These problems may occur some time after you take a dose. Tell your doctor right away if you develop any new or worsening symptoms such as slowed or shallow breathing or irregular heartbeat. Your doctor will perform heart and lung function tests to check for side effects while you take Dolophine Solution. Keep all doctor and laboratory appointments. Talk with your doctor and be sure you understand the risks and benefits of using Dolophine Solution.
Do not take more than the recommended dose or take Dolophine Solution more often than it is prescribed. This can lead to overdose and possible death.
Treating moderate to severe pain that is not relieved by other pain medicines. It is used in the temporary treatment of narcotic addiction as part of a treatment program in patients who are unable to take medicine by mouth. It may also be used for other conditions as determined by your doctor.
Dolophine Solution is a narcotic analgesic. It works by acting on opiate pain receptors in the brain and on smooth muscle to provide pain relief.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Dolophine Solution. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Dolophine Solution. Tell your health care provider if you are taking any other medicines, especially any of the following:
This may not be a complete list of all interactions that may occur. Ask your health care provider if Dolophine Solution may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Dolophine Solution as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Dolophine Solution.
When used for long periods of time or at high dose, Dolophine Solution may not work as well and may require higher doses to obtain the same effect as when originally taken. This is known as TOLERANCE. Talk with your doctor if Dolophine Solution stops working well. Do not take more than prescribed.
Some people who use Dolophine Solution for a long time may develop a need to continue taking it. People who take high doses are also at risk. This is known as DEPENDENCE or addiction.
If you stop taking Dolophine Solution suddenly, you may have WITHDRAWAL symptoms. These may include convulsions, tremor, stomach and muscle cramps, vomiting, and sweating. Do not stop therapy suddenly or change the dosage without asking your doctor. Discuss overuse with your doctor or pharmacist.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Constipation; dizziness; drowsiness; dry mouth; headache; increased sweating; itching; lightheadedness; nausea; pain, redness, or swelling at the injection site; vomiting; weakness.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); confusion; decreased sexual desire or ability; excessive drowsiness; fainting; fast, slow, or irregular heartbeat; hallucinations; loss of appetite; menstrual changes; mental or mood changes (eg, agitation, disorientation, exaggerated sense of well-being); seizures; severe or persistent dizziness or lightheadedness; severe or persistent pain, redness, or swelling at the injection site; shortness of breath; slow or shallow breathing; swelling of the arms, feet, or legs; trouble sleeping; trouble urinating; unusual bruising or bleeding.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: Dolophine side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include cold and clammy skin; coma; fainting; fast, slow, or irregular heartbeat; muscle weakness; pinpoint pupils; severe dizziness, drowsiness, or lightheadedness; slow, shallow, or difficult breathing.
Store Dolophine Solution at 77 degrees F (25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Dolophine Solution out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Dolophine Solution. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Mitokebir may be available in the countries listed below.
Mitomycin is reported as an ingredient of Mitokebir in the following countries:
International Drug Name Search
Metformin-Zentiva may be available in the countries listed below.
Metformin is reported as an ingredient of Metformin-Zentiva in the following countries:
International Drug Name Search
Darolan Hoestprikkeldempend may be available in the countries listed below.
Dextromethorphan hydrobromide (a derivative of Dextromethorphan) is reported as an ingredient of Darolan Hoestprikkeldempend in the following countries:
International Drug Name Search
Ferromas may be available in the countries listed below.
Ferrous Sulfate is reported as an ingredient of Ferromas in the following countries:
International Drug Name Search
Meropenem Labatec may be available in the countries listed below.
Meropenem trihydrate (a derivative of Meropenem) is reported as an ingredient of Meropenem Labatec in the following countries:
International Drug Name Search
Novell-Eutropin may be available in the countries listed below.
Somatropine is reported as an ingredient of Novell-Eutropin in the following countries:
International Drug Name Search
Anelat may be available in the countries listed below.
Folic Acid is reported as an ingredient of Anelat in the following countries:
International Drug Name Search
Inate may be available in the countries listed below.
Zinc Sulfate is reported as an ingredient of Inate in the following countries:
International Drug Name Search
Generic Name: vincristine (Intravenous route)
vin-KRIS-teen
For intravenous use only; fatal if given intrathecally. Intravenous needle or catheter must be properly positioned before any vincristine is injected as leakage into the surrounding tissue may cause considerable irritation. If extravasation occurs, the injection should be discontinued immediately, and any remaining portion of the dose should then be introduced into another vein. Local injection of hyaluronidase and the application of moderate heat to the area of leakage help disperse the drug and are thought to minimize discomfort and the possibility of cellulitis .
In the U.S.
Available Dosage Forms:
Therapeutic Class: Antineoplastic Agent
Pharmacologic Class: Mitotic Inhibitor
Vincristine belongs to the group of medicines known as antineoplastic agents. It is used to treat some kinds of cancer as well as some noncancerous conditions.
Vincristine interferes with the growth of cancer cells, which are eventually destroyed. Since the growth of normal body cells may also be affected by vincristine, other effects will also occur. Some of these may be serious and must be reported to your doctor. Other effects, such as hair loss, may not be serious but may cause concern. Some effects may not occur for months or years after the medicine is used.
Before you begin treatment with vincristine, you and your doctor should talk about the good this medicine will do as well as the risks of using it.
Vincristine is to be administered only by or under the immediate supervision of your doctor.
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
This medicine has been tested in children and has not been shown to cause different side effects or problems than it does in adults.
Nervous system effects may be more likely to occur in the elderly, who are usually more sensitive to the effects of vincristine.
| Pregnancy Category | Explanation | |
|---|---|---|
| All Trimesters | D | Studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy in a life threatening situation or a serious disease, may outweigh the potential risk. |
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.
Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:
This section provides information on the proper use of a number of products that contain vincristine. It may not be specific to Oncovin. Please read with care.
Vincristine is often given together with certain other medicines. If you are using a combination of medicines, it is important that you receive each one at the proper time. If you are taking some of these medicines by mouth, ask your health care professional to help you plan a way to take them at the right times.
While you are using this medicine, it may be necessary to drink extra fluids so that you will pass more urine. This will help prevent kidney problems and keep your kidneys working well. Ask your doctor if this is necessary for you.
This medicine sometimes causes nausea and vomiting. However, it is very important that you continue to receive the medicine, even if you begin to feel ill. Ask your health care professional for ways to lessen these effects.
Vincristine frequently causes constipation and stomach cramps. Your doctor may want you to take a laxative. However, do not decide to take these medicines on your own without first checking with your doctor.
The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.
The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.
It is very important that your doctor check your progress at regular visits to make sure that vincristine is working properly and to check for unwanted effects.
While you are being treated with vincristine, and after you stop treatment with it, do not have any immunizations (vaccinations) without your doctor's approval. Vincristine may lower your body's resistance and there is a chance you might get the infection the immunization is meant to prevent. Other people living in your household should not take or should not have recently taken oral polio vaccine since there is a chance they could pass the polio virus on to you. Also, avoid other persons who have taken oral polio vaccine. Do not get close to them, and do not stay in the same room with them for very long. If you cannot take these precautions, you should consider wearing a protective face mask that covers the nose and mouth.
If vincristine accidentally seeps out of the vein into which it is injected, it may damage some tissues and cause scarring. Tell the doctor or nurse right away if you notice redness, pain, or swelling at the place of injection.
Along with their needed effects, medicines like vincristine can sometimes cause unwanted effects such as blood problems, nervous system problems, loss of hair, and other side effects. These and others are described below. Also, because of the way these medicines act on the body, there is a chance that they might cause other unwanted effects that may not occur until months or years after the medicine is used. Discuss these possible effects with your doctor.
Check with your doctor immediately if any of the following side effects occur:
Check with your doctor as soon as possible if any of the following side effects occur:
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Other side effects may occur that usually do not need medical attention. This medicine often causes a temporary loss of hair. After treatment with vincristine has ended, or sometimes even during treatment, normal hair growth should return.
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
See also: Oncovin side effects (in more detail)
The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.
Quit may be available in the countries listed below.
Nicotine is reported as an ingredient of Quit in the following countries:
International Drug Name Search
Gemfibrozilo Bexal may be available in the countries listed below.
Gemfibrozil is reported as an ingredient of Gemfibrozilo Bexal in the following countries:
International Drug Name Search
Vitafluid may be available in the countries listed below.
Retinol palmitate (a derivative of Retinol) is reported as an ingredient of Vitafluid in the following countries:
International Drug Name Search
Escitalopram ratiopharm may be available in the countries listed below.
Escitalopram oxalate (a derivative of Escitalopram) is reported as an ingredient of Escitalopram ratiopharm in the following countries:
International Drug Name Search
Sasapyrine may be available in the countries listed below.
Sasapyrine (JAN) is known as Salsalate in the US.
International Drug Name Search
Glossary
| JAN | Japanese Accepted Name |
Epitrigine may be available in the countries listed below.
Lamotrigine is reported as an ingredient of Epitrigine in the following countries:
International Drug Name Search
Dimor may be available in the countries listed below.
Loperamide hydrochloride (a derivative of Loperamide) is reported as an ingredient of Dimor in the following countries:
International Drug Name Search
Amoxi 1A Pharma may be available in the countries listed below.
Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amoxi 1A Pharma in the following countries:
International Drug Name Search
Rocornal may be available in the countries listed below.
Trapidil is reported as an ingredient of Rocornal in the following countries:
International Drug Name Search
Citarabina Microsules may be available in the countries listed below.
Cytarabine is reported as an ingredient of Citarabina Microsules in the following countries:
International Drug Name Search
Simvastatine Hexal may be available in the countries listed below.
Simvastatin is reported as an ingredient of Simvastatine Hexal in the following countries:
International Drug Name Search
Laboxina may be available in the countries listed below.
Clonixin lysine salt (a derivative of Clonixin) is reported as an ingredient of Laboxina in the following countries:
International Drug Name Search
Ranitidina Angenerico may be available in the countries listed below.
Ranitidine hydrochloride (a derivative of Ranitidine) is reported as an ingredient of Ranitidina Angenerico in the following countries:
International Drug Name Search
Rec.INN
N02CX06
0026020-55-3
C21-H21-N-O2
319
Antimigraine agent
1-Propanamine, 3-benzofuro[3,2-c][1]benzoxepin-6(12H)-ylidene-N,N-dimethyl-
International Drug Name Search
Glossary
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Spulyt may be available in the countries listed below.
Bromhexine hydrochloride (a derivative of Bromhexine) is reported as an ingredient of Spulyt in the following countries:
International Drug Name Search
Sertraline-GA may be available in the countries listed below.
Sertraline hydrochloride (a derivative of Sertraline) is reported as an ingredient of Sertraline-GA in the following countries:
International Drug Name Search
Calciumfolinate Teva may be available in the countries listed below.
Calcium Folinate is reported as an ingredient of Calciumfolinate Teva in the following countries:
International Drug Name Search
Aspirina Plus may be available in the countries listed below.
Acetylsalicylic Acid is reported as an ingredient of Aspirina Plus in the following countries:
Caffeine is reported as an ingredient of Aspirina Plus in the following countries:
International Drug Name Search
Fluconazol Calox may be available in the countries listed below.
Fluconazole is reported as an ingredient of Fluconazol Calox in the following countries:
International Drug Name Search
Tropicamidã may be available in the countries listed below.
Tropicamide is reported as an ingredient of Tropicamidã in the following countries:
International Drug Name Search
Flexital may be available in the countries listed below.
Pentoxifylline is reported as an ingredient of Flexital in the following countries:
International Drug Name Search
Sicaden may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Dimeticone is reported as an ingredient of Sicaden in the following countries:
International Drug Name Search
Riboxatin may be available in the countries listed below.
Oxaliplatin is reported as an ingredient of Riboxatin in the following countries:
International Drug Name Search
Tercyd may be available in the countries listed below.
Terbinafine is reported as an ingredient of Tercyd in the following countries:
International Drug Name Search
Haemocomplettan P may be available in the countries listed below.
Fibrinogen, human is reported as an ingredient of Haemocomplettan P in the following countries:
International Drug Name Search
Tranalpha may be available in the countries listed below.
Trandolapril is reported as an ingredient of Tranalpha in the following countries:
International Drug Name Search
Sertralina Pharmakern may be available in the countries listed below.
Sertraline is reported as an ingredient of Sertralina Pharmakern in the following countries:
International Drug Name Search
Prop.INN
0014679-73-3
C11-H12-N4-O2
232
Vasodilator, peripheric
Antihypertensive agent
Hydrazinecarboxylic acid, 2-(1-phthalazinyl)-, ethyl ester
International Drug Name Search
Glossary
| BAN | British Approved Name |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Prop.INN | Proposed International Nonproprietary Name (World Health Organization) |
Suprelorin may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Deslorelin acetate (a derivative of Deslorelin) is reported as an ingredient of Suprelorin in the following countries:
International Drug Name Search
Langa Dip may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Cypermethrin is reported as an ingredient of Langa Dip in the following countries:
International Drug Name Search
Uridoz may be available in the countries listed below.
Fosfomycin tromethamine (a derivative of Fosfomycin) is reported as an ingredient of Uridoz in the following countries:
International Drug Name Search
Saleco may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Salinomycin sodium salt (a derivative of Salinomycin) is reported as an ingredient of Saleco in the following countries:
International Drug Name Search
Rec.INN
L01AD05
0092118-27-9
C9-H19-Cl-N3-O5-P
315
Antineoplastic agent
(±)-Diethyl [1-[3-(2-chloroethyl)-3-nitrosoureido]ethyl]phosphonate
International Drug Name Search
Glossary
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Tibolux may be available in the countries listed below.
Tibolone is reported as an ingredient of Tibolux in the following countries:
International Drug Name Search
Butylpan may be available in the countries listed below.
Scopolamine butylbromide (a derivative of Scopolamine) is reported as an ingredient of Butylpan in the following countries:
International Drug Name Search
Cilosmerck may be available in the countries listed below.
Cilostazol is reported as an ingredient of Cilosmerck in the following countries:
International Drug Name Search
Nasocalma may be available in the countries listed below.
Ephedrine is reported as an ingredient of Nasocalma in the following countries:
International Drug Name Search
Treating heartburn, upset stomach, indigestion, nausea, diarrhea, or symptoms associated with eating or drinking too much. It may be used to decrease the number of bowel movements and make the stool firmer. It may also be used to treat other conditions as determined by your doctor.
Bismuth Subsalicylate Chewable Tablets are a salicylate. The way that it works is not fully understood. It is thought to limit secretions in the digestive tract, reduce inflammation in the stomach and intestines, and inhibit the growth of certain bacteria and viruses that can cause intestinal tract diseases.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Bismuth Subsalicylate Chewable Tablets. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Bismuth Subsalicylate Chewable Tablets. Tell your health care provider if you are taking any other medicines, especially any of the following:
This may not be a complete list of all interactions that may occur. Ask your health care provider if Bismuth Subsalicylate Chewable Tablets may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Bismuth Subsalicylate Chewable Tablets as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Bismuth Subsalicylate Chewable Tablets.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Temporary and harmless darkening of the tongue or stool.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); fever; hearing loss; nausea; ringing in the ears; severe constipation; vomiting.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: Bismuth Subsalicylate side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include coma; confusion; dehydration; dizziness; new or worsening nausea; ringing in the ears; seizures; unusual bruising or bleeding; vomiting.
Store Bismuth Subsalicylate Chewable Tablets at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Keep Bismuth Subsalicylate Chewable Tablets out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Bismuth Subsalicylate Chewable Tablets. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Spectrum may be available in the countries listed below.
Ceftazidime pentahydrate (a derivative of Ceftazidime) is reported as an ingredient of Spectrum in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
In the US, Potassium Chloride (potassium chloride systemic) is a member of the drug class minerals and electrolytes and is used to treat Hypokalemia and Prevention of Hypokalemia.
US matches:
Ph. Int.
A12BA01,B05XA01
0007447-40-7
KCl
74
Electrolyte solution
Treatment of potassium deficiency
Treatment of alkalosis
Potassium chloride
International Drug Name Search
Glossary
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Ph. Int. | Pharmacopoea Internationalis |
| USAN | United States Adopted Name |
